ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BDSX vs YDES // EV/EBITDA & P/E VALUATION

Biodesix Inc. (NASDAQ) VS. YD Bio Limited (NASDAQ) • 15-METRIC TALLY: BDSX 3 — YDES 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BDSX VS. YDES) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BDSX YDES SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 28.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -20.00% -15.00 YDES /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -9.02% -1.93% -7.09 YDES /fcf-yield <GO>
Operating Margin -31.50% -60.00% +28.50 BDSX /operating-margins <GO>
Net Profit Margin -39.90% -60.00% +20.10 BDSX /net-margins <GO>
Revenue Growth (YoY) 24.10% 16.90% +7.20 BDSX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 13.44 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.0 52.3 -8.37 YDES /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $260.8M $415.8M -$155.0M YDES /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BDSX REV YDES REV BDSX GROSS % YDES GROSS % BDSX FCF YDES FCF
FY 2025 $88.5M $596.8K — 28.1% -$23.5M -$8.0M
FY 2024 $71.3M $510.4K — 30.4% -$51.9M -$1.3M
FY 2023 $49.1M $350.1K — — -$22.9M -$55.7K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BDSX // BETA —
YDES // BETA —